Targeted proteomics using parallel reaction monitoring confirms salivary proteins indicative of metastatic triple-negative breast cancer.

Giri, Kuldeep; Maity, Sudipa; Ambatipudi, Kiran

Giri, Kuldeep; Maity, Sudipa; Ambatipudi, Kiran.

Afiliación

Giri K; Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Maity S; Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Ambatipudi K; Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India. Electronic address: kiran.ambatipudi@bt.iitr.ac.in.

J Proteomics ; 267: 104701, 2022 09 15.

Article en En | MEDLINE | ID: mdl-35995384

Asunto(s)

Neoplasias de la Mama Triple Negativas; Biomarcadores; Humanos; Lipocalina 1; Lipocalinas; Espectrometría de Masas; Proteínas de Microfilamentos; Proteómica/métodos; Proteínas y Péptidos Salivales/metabolismo; Neoplasias de la Mama Triple Negativas/metabolismo

Palabras clave

Absolute quantitation; Parallel reaction monitoring; Saliva proteins markers; Targeted proteomic; Triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Proteomics Asunto de la revista: BIOQUIMICA Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google